Cell-Based Assays Market Report to 2030

細胞ベースアッセイの世界市場(~2030年)

◆タイトル:Cell-Based Assays Market Report to 2030
◆商品コード:VGA21MA001
◆調査・発行会社:visiongain
◆発行日:2021年5月
◆ページ数:454
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Sigle User(1名様閲覧用、1年間、印刷不可)USD5,199 ⇒換算¥665,472見積依頼/購入/質問フォーム
Global Site License(法人閲覧用、1年間、印刷可)USD9,099 ⇒換算¥1,164,672見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、世界の細胞ベースアッセイの市場について調査・分析し、レポート概要、イントロダクション、エグゼクティブサマリー、市場動向、新型コロナウイルス感染症の影響、市場予測、製品別(機器、消耗品、ソフトウェア、サービス)分析、技術別(ハイスループットスクリーニング(HTS)、自動液体処理、フローサイトメトリー、ラベルフリー検出)分析、用途別(創薬、基礎研究、予測技術、ADME)分析、エンドユーザー別(製薬・バイオテクノロジー企業、学術機関、委託研究機関(CRO))分析、地域別分析、主要企業、技術動向・将来見通し、結論などの項目を掲載しています。
・レポート概要
・イントロダクション
・エグゼクティブサマリー
・市場動向
・新型コロナウイルス感染症の影響
・市場予測
・世界の細胞ベースアッセイ市場規模:製品別(機器、消耗品、ソフトウェア、サービス)
・世界の細胞ベースアッセイ市場規模:技術別(ハイスループットスクリーニング(HTS)、自動液体処理、フローサイトメトリー、ラベルフリー検出)
・世界の細胞ベースアッセイ市場規模:用途別(創薬、基礎研究、予測技術、ADME)
・世界の細胞ベースアッセイ市場規模:エンドユーザー別(製薬・バイオテクノロジー企業、学術機関、受託研究機関(CRO))
・世界の細胞ベースアッセイ市場規模:地域別
・主要企業
・技術動向・将来見通し
・結論

The cell-based assay market is estimated to grow at a CAGR of xx% over the forecast period. The rising preference for cell-based assays in drug discovery, increasing funding for cell-based research, and growth in the number of drug discovery activities are the key factors supporting the growth of the market.

Evolving economies, growing pandemic risk and communicable diseases and application of cell-based assay in oncology research area is assured to provide profitable growth opportunities to the players in this market. For instance, phenotypic screening approaches are again rising in popularity in the drug discovery business, there is a need for robust and efficient assays that enable the study of the nervous system. Phenotypic assays can be highly predictive for infectious and metabolic diseases, however, for more complex disease areas such as the nervous system and cancer, more effort needs to be placed in designing sufficient and accurate models and assays. Cell-based assays are now emerging, such as for pain sensitisation and also in the screening of clinical compounds to treat Alzheimer’s disease. It is hoped that the further development of these cell-based assays will open the door for phenotypic screening approaches in nervous system and pain drug discovery thus, bolstering the growth of the market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

The report provides a profound understanding into the global cell-based assay market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the cell-based assay industry in any manner.

As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

In this brand-new 454-page report you will receive 283 charts– all unavailable elsewhere. The 454-page Visiongain report provides clear detailed insight into the cell-based assay market. Discover the key trends and development in the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
• Global cell-based assay market forecasts from 2020-2030
• This report also breaks down the revenue forecast to 2030 for the global cell-based assay market by product, technology, application and end-user:
By Product
• Consumables
• Instruments
• Software & Services
By Technology
• Automated Handling
• Flow Cytometry
• Label-Free Detection
• High-Throughput Screening
By Application
• Drug Discovery
• Basic Research
• ADME Studies
• Predictive Technology
By End-User
• Pharma & Biotech Companies
• Academic Institutes
• CROs
This report discusses the market trends and developments of each submarket.

Our study discusses the selected leading companies that are the major players in the cell-based assay market:
• DiscoverX Corporation (Eurofins DiscoverX)
• Thermo Fisher Scientific
• Cell Assay Innovations, Inc.
• InSphero AG
• QGel SA.
• Becton, Dickinson and Company
• Promega Corporation
• BioVision, Inc.
• Marin Biologic Laboratories
• Molecular Devices, LLC. (Danaher Corporation)
• Porsolt
• CYTOO SA
• Pharmaceutical Product Development, LLC.
• ProQinase GmbH
• Charles River Laboratories International, Inc.
• BioAgilytix Labs
• SGS Group
• Perkin Elmer Inc.
• General Electric Company (GE Healthcare)
• F. Hoffmann-La Roche AG
• Merck KGaA
• Corning Inc.
• Bio-Rad Laboratories
Visiongain’s study is intended for anyone requiring commercial analyses for the global cell-based assay market. You find data, trends and predictions.

【レポートの目次】

1 Report Overview
1.1 Cell-Based Assays Market Segmentation
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.7 COVID-19 Impact: Recovery Scenarios
1.8 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQs)
1.10 Associated Reports
1.11 About Visiongain
2. Introduction to Cell-Based Assays
2.1 Cell-Based Assays Overview
2.2 Cost of New Drug Discovery and Development Reaches $1.5bn – Companies Constantly Looking for Increased Efficiencies
2.3 Drug Discovery Approaches – Target-Based and Phenotype-Based Discovery
2.4 Drug Screening Assays
2.5 Animal Models Present In Vivo Conditions: But Do Results Translate to Humans?
2.6 Biochemical Assays and their Advantages over Animal Models
2.7 Applications of Biochemical Assays
2.8 Lead Identification and Toxicity Testing
2.9 Cell-Based Assays and their Advantages
2.10 2D vs 3D Cell-Based Assays
2.11 Advanced Cell-Based Assays
2.12 The Different Assay Detection Methods and Technologies
2.13 Cells used in Cell-Based Assays
2.14 Immortalised Cell Lines – Convenient but not Truly Representative of Normal Human Cell Lines
2.15 Primary Cells: Closer to the In Vivo Environment
2.16 Stem Cells: Potential to Overcome Limitations of Primary cells and Immortalised Cell Lines
2.17 Uses for Cell-Based Assays in Drug Discovery and Development
2.18 High Throughput Screening: Greatly Increases Efficiency
3. Executive Summary
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Trends
4.5 SWOT Analysis of the Cell-Based Assays Market
4.6 STEP Analysis of the Cell-Based Assays Market
4.7 Porter’s Five Forces Analysis
5. COVID Impact: Cell-Based Assays Market 2020
6. Global Cell-Based Assays Market Forecast 2020-2030
6.1 Global Cell-based Assays Market Forecasts 2020-2030
6.2 Global Cell-based Assays Market: COVID-19 Recovery Revenue Forecasts (V, U, W, L) 2020-2030
7. Cell-Based Assays Market by Product: Forecasts 2020-2030
7.1 Global Instruments Market: Revenue Forecasts 2020-2030
7.1.1 Increasing Focus on Drug Discovery is Driving the Instruments Segment
7.2 Global Instruments Market: Recovery Revenue Forecasts (V, U, W, L)
7.2.1 Global Microplates Market: Revenue Forecast 2020-2030
7.2.2 Global Microplates Market: Recovery Revenue Forecasts (V, U, W, L)
7.2.3 Global Microplate Reader Market: Revenue Forecasts 2020-2030
7.2.4 Global Microplate Readers Market: Recovery Revenue Forecasts (V, U, W, L)
7.2.5 Global Liquid Handling System Market: Revenue Forecasts 2020-2030
7.2.6 Global Liquid Handling System Market: Recovery Revenue Forecasts (V, U, W, L)
7.3 Global Consumables Market: Revenue Forecasts 2020-2030
7.3.1 Surge of Investments in the Field of Pharmaceuticals and Drug Discovery
7.3.2 Global Consumables Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.3 Global Reagents Market: Revenue Forecasts 2020-2030
7.3.3.1 .Global Reagents Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.4 Global Assay Kits Market: Revenue Forecasts 2020-2030
7.3.4.1Global Assay Kits Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.5 Global Cell Lines Market: Revenue Forecasts 2020-2030
7.3.6 Global Cell Lines Market: Recovery Revenue Forecasts (V, U, W, L)
7.3.7 Global Probes and Labels Market: Revenue Forecasts 2020-2030
7.3.8 Global Probes and Labels Market: Recovery Revenue Forecasts (V, U, W, L)
7.4 Global Software Market: Revenue Forecasts 2020-2030
7.4.1 Technological Advancement in the Software Segment boosting its Adoption
7.4.2 Global Software Market: Recovery Revenue Forecasts (V, U, W, L)
7.5 Global Services Market: Revenue Forecasts 2020-2030
7.5.1 Rising Outsourcing of Product R&D by Pharmaceutical & Biotechnology Companies
7.5.2 Global Services Market: Recovery Revenue Forecasts (V, U, W, L)
8. Cell-Based Assays Market by Technology: Forecasts 2020-2030
8.1 Global High Throughput Screening Market: Revenue Forecasts 2020-2030
8.1.1 HTS is Vital in drug R&D
8.1.2 Global High Throughput Screening Market: Recovery Revenue Forecasts (V, U, W, L)
8.2 Global Automated Liquid Handling Market: Revenue Forecasts 2020-2030
8.2.1 Rising Technological Advances in the Area of Automated Liquid Handing
8.2.2 Global Automated Liquid Handling Market: Recovery Revenue Forecasts (V, U, W, L)
8.3 Global Flow Cytometry Market: Revenue Forecasts 2020-2030
8.3.1 One of the Widely Used Technology in the Pharmaceutical & Biotechnology Industry
8.3.2 Global Flow Cytometry Market: Recovery Revenue Forecasts (V, U, W, L)
8.4 Global Label-Free Detection Market: Revenue Forecasts 2020-2030
8.4.1 Label-Free Detection Technology is a Promising Analytical Tool in Cell-Based Assays
8.4.2 Global Label-Free Detection Market: Recovery Revenue Forecasts (V, U, W, L)
9. Cell-Based Assays Market by Application: Forecasts 2020-2030
9.1 Global Drug Discovery Market: Revenue Forecasts 2020-2030
9.1.1 Recent Developments in the Cell-Based Assays for Drug Discovery is Propelling the Segment Growth
9.1.2 Global Drug Discovery Market: Recovery Revenue Forecasts (V, U, W, L)
9.2 Global Basic Research Market: Revenue Forecasts 2020-2030
9.2.1 Segment Growth
9.2.2 Global Basic Research Market: Recovery Revenue Forecasts (V, U, W, L)
9.3 Global Predictive Technology Market: Revenue Forecasts 2020-2030
9.3.1 Growing Demand for the Advanced Technologies for Disease Diagnosis and Drug Development
9.3.2 Global Predictive Technology Market: Recovery Revenue Forecasts (V, U, W, L)
9.4 Global ADME Market: Revenue Forecasts 2020-2030
9.4.1 Introduction of Technologically Advanced Computer-Based Testing Models
9.4.2 Global ADME Toxicity Testing Market: Recovery Revenue Forecasts (V, U, W, L)
10. Cell-Based Assays Market by End-User: Forecasts 2020-2030
10.1 Global Pharma & Biotech Companies Market: Revenue Forecasts 2020-2030
10.1.1 Largest Revenue Grossing Segment
10.1.2 Global Pharma & Biotech Companies Market: Recovery Revenue Forecasts (V, U, W, L)
10.2 Global Academic Institutions Market: Revenue Forecasts 2020-2030
10.2.1 One of The Fast Growing Segment
10.2.2 Global Academic Institutions Market: Recovery Revenue Forecasts (V, U, W, L)
10.3 Global Contract Research Organizations (CROs) Market: Revenue Forecasts 2020-2030
10.3.1 Pharmaceutical Outsourcing has witnessed a Significant Transformation over The Past Few Decades
10.3.2 Global Contract Research Organizations (CROs) Market: Recovery Revenue Forecasts (V, U, W, L)
11. Regional and Leading National Cell-Based Assays Market Forecasts 2020-2030
11.1 Regional Breakdown of the Global Cell-Based Assays Market, 2020-2030
11.2 Global Cell-Based Assays Market: Regional Forecast 2020-2030
11.3 North America Cell-Based Assays Revenue Forecast 2020-2030
11.3.1 Largest Revenue-Generating Regional Market
11.3.2 North America Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.3.3 The US Cell-Based Assays Revenue Forecast 2020-2030
11.3.4 U.S Dominated the North America Market
11.3.5 Stringent Demands for Safety Data from the FDA
11.3.6 US Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.3.7 Canada Cell-Based Assays Revenue Forecast 2020-2030
11.3.8 Canada is one of the leading locations for clinical trials for the pharma industry
11.3.9 Canada Pharmaceutical Market has an opportunity to flourish
11.3.10 Canada Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4 European Union (EU) Cell-Based Assays Market 2020-2030
11.4.1 Increasing Research Activities In European Region
11.4.2 Growing User Demand for Advanced Products In European Region
11.4.3 European Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.4 Europe National Market Share Breakdown, 2020, 2025 and 2030
11.4.5 European Market: Main National Market Forecasts, 2020-2030
11.4.6 German Cell-Based Assay Revenue Forecast, 2020-2030
11.4.7 Pharmaceutical companies in Germany are aggressively involved in drug development
11.4.8 German market will remain the largest in Europe
11.4.9 Germany Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.10 French Cell-Based Assays Revenue Forecast, 2020-2030
11.4.11 Research Institutes in France Focuses in collaboration with foreign institutions
11.4.12 Growing Adoption of Advanced technology
11.4.13 French Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.14 UK Cell-Based Assays Revenue Forecast, 2020-2030
11.4.15 Collaborations among the biotech companies in the UK
11.4.16 The UK is the third biggest cell-based assays
11.4.17 UK Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.18 Spanish Cell-Based Assays Revenue Forecast, 2020-2030
11.4.19 Spain is emerging as an important biotechnology hub in Europe
11.4.20 Rising Biotechnology Research Investment in Spain
11.4.21 Spanish Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.22 Italian Cell-Based Assays Revenue Forecast, 2020-2030
11.4.23 Partner research organizations and biotech start-ups involved in developing cell-based assay solutions and services
11.4.24 High demand for advanced medicines
11.4.25 Italian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.26 Russia Cell-Based Assays Revenue Forecast, 2020-2030
11.4.27 Improving regulatory policies to develop the domestic pharmaceutical industry and Collaboration among Biotechnology Companies and Research Institutes
11.4.28 Russian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.29 Sweden Cell-Based Assays Revenue Forecast, 2020-2030
11.4.30 Sweden’s pharmaceutical sector is becoming increasingly important to the country’s economy
11.4.31 Sweden is expected to acquire the seventh largest share of the European cell-based assays market
11.4.32 Sweden Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.33 Denmark Cell-Based Assays Revenue Forecast, 2020-2030
11.4.34 Denmark is an increasingly attractive location for businesses that depend on clinical trials
11.4.35 Many well-established Contract Research Organizations with expertise in setting up
11.4.36 Denmark Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.37 Finland Cell-Based Assays Revenue Forecast, 2020-2030
11.4.38 Finland has seen a dynamic bioscience industry spring up and it is one of the fast-growing markets
11.4.39 Finland Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.40 Norway Cell-Based Assays Revenue Forecast, 2020-2030
11.4.41 High Investment in the Healthcare Sector
11.4.42 The growing pharmaceutical industry in Norway
11.4.43 Norway Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.4.44 Rest of Europe Cell-Based Assays Revenue Forecast, 2020-2030
11.4.45 Rest of Europe Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5 Asia-Pacific Cell-Based Assays Market 2020-2030
11.5.1 Asia Pacific Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.2 APAC Countries National Breakdown, 2020, 2025 and 2030
11.5.3 APAC Market National Forecasts, 2020-2030
11.5.4 Japanese Cell-Based Assays Revenue Forecast, 2020-2030
11.5.5 Japanese biotechnology and pharmaceutical companies focus on strategic collaborations
11.5.6 Japan has the world’s second-largest pharmaceutical market
11.5.7 Japanese Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.8 Chinese Cell-Based Assay Revenue Forecast, 2020-2030
11.5.9 One of the most important markets in the world
11.5.10 China is the second-largest cell-based assay market amongst the APAC Region
11.5.11 Chinese Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.12 Indian Cell-Based Assays Revenue Forecast, 2020-2030
11.5.13 India has been gaining increasing significance in the global drug R&D
11.5.14 India is an attractive market for pharmaceutical companies
11.5.15 Indian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.5.16 Rest of APAC Cell-Based Assays Revenue Forecast, 2020-2030
11.5.17 Rest of APAC Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6 LATAM Cell-Based Assays Market 2020-2030
11.6.1 Latin America Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6.2 LATAM Countries National Breakdown, 2020, 2025 and 2030
11.6.3 LATAM Countries National Forecasts, 2020-2030
11.6.4 Brazilian Cell-Based Assays Revenue Forecast, 2020-2030
11.6.5 Investment by pharmaceutical & biotechnology companies in this region
11.6.6 Largest Market in Latin America
11.6.7 Brazilian Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6.8 Mexico Cell-Based Assays Revenue Forecast, 2020-2030
11.6.9 Significant local production of active ingredients and finished products
11.6.10 Mexico has signed many Free Trade Agreements
11.6.11 Mexico Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.6.12 Rest of LATAM Cell-Based Assays Revenue Forecast, 2020-2030
11.6.13 Rest of LATAM Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
11.7 Middle-East & Africa (MEA) Cell-Based Assays Market 2020-2030
11.7.1 MEA Cell-Based Assays Market: Recovery Revenue Forecasts (V, U, W, L)
12. Leading Companies in the Cell-Based Assays Market, 2020-2030
12.1 DiscoverX Corporation (Eurofins DiscoverX)
12.2 Thermo Fisher Scientific
12.3 Cell Assay Innovations, Inc.
12.4 InSphero AG
12.5 QGel SA.
12.6 Becton, Dickinson and Company
12.7 Promega Corporation
12.8 BioVision, Inc.
12.9 Marin Biologic Laboratories
12.10 Molecular Devices, LLC. (Danaher Corporation)
12.11 Porsolt
12.12 CYTOO SA
12.13 Pharmaceutical Product Development, LLC.
12.14 ProQinase GmbH
12.15 Charles River Laboratories International, Inc.
12.16 BioAgilytix Labs
12.17 SGS Group
12.18 Perkin Elmer Inc.
12.19 General Electric Company (GE Healthcare)
12.20 F. Hoffmann-La Roche AG
12.21 Merck KGaA
12.22 Corning Inc.
12.23 Bio-Rad Laboratories
13. Cell-Based Assays Technology, Trends and Future Outlook
13.1 Stem Cells: Vast Potential
13.2 The Benefits of Using Stem Cells in Cell-Based Assays
13.3 iPSCs: An Uncontroversial and Abundant Source
13.4 Companies Providing Stem Cell-Based Assays
13.5 Toxicity Testing: Important Field for Cell-Based Assays
13.6 3D Systems: The Advantages of Next Generation of Cell Systems
13.7 Complexity of 3D Systems is a Challenge but many are reaching the Market
13.8 Organoids – The Future of Drug Development
13.9 Bio-Printing for Drug Development: Using 3D Printing Technology
13.10 Increasing Outsourcing of Cell-Based Assays
13.11 Label-Free Technology
13.12 GPCRs: A Common Drug and Drug Discovery Target
13.13 Allosteric GPCRs
13.14 Increasing Miniaturisation and Automation
13.15 Advantages of Miniaturisation
13.16 Advantages of Automation
13.17 Microfluids are Set to be a Trend
13.18 Multiplexing: Improves Efficiency of Cell-Based Assays
13.19 High Content Screening: A Well-Established Tool
13.20 Cell-Based Assays for the Development of Biologics
14. Conclusions
14.1 Growth Has Been Driven by Advantages of Cell-Based Assays
14.2 Current Status of the Market and its Growth Drivers
14.3 The Most Dominant National Markets and Emerging Countries
14.4 Future Trends and Technology



★調査レポート[細胞ベースアッセイの世界市場(~2030年)] ( Cell-Based Assays Market Report to 2030 / VGA21MA001) 販売に関する免責事項
[細胞ベースアッセイの世界市場(~2030年)] ( Cell-Based Assays Market Report to 2030 / VGA21MA001) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆